Scott-Coombes D M, Rees J, Jones G, Stechman M J
Department of Endocrine Surgery, C2 Office, University Hospital of Wales, Heath Park, Cardiff, CF14 4XW, UK.
Department of Radiology, University Hospital of Wales, Cardiff, UK.
World J Surg. 2017 Jun;41(6):1494-1499. doi: 10.1007/s00268-017-3891-0.
Ultrasound and Tc99mMIBI scans are used to localise parathyroid tumours in sporadic primary hyperparathyroidism (pHPT). Intra-operative PTH (ioPTH) assay facilitates unilateral neck exploration (UNE). When both ultrasound and MIBI are negative, it is our policy to explore the left side of the neck and only proceed to bilateral neck exploration (BNE) when either a tumour is not found or when ioPTH does not fall to >50% of the highest pre-excision value. The aim of this study was to investigate the outcome of our approach to 'double negative' patients.
A retrospective analysis of patients undergoing primary parathyroidectomy for pHPT. Data were obtained from a prospective surgical database and the hospital electronic patient record.
Between January 2004 and November 2014, 746 patients underwent a parathyroidectomy for pHPT. Those who did not have both pre-operative scans, ioPTH or a minimum of 6-month follow-up were excluded. Of 552 patients, 111 (20%) had double negative scans (group A), and in 441, either one or both scans were positive (group B). Median age was 61.5 years (range 10-88). Pre-operative PTH level was significantly lower in group A: 11.8 pmol/l (range 3.1-38.8) versus 14.9 pmol/l (range 2.8-101.6; P < 0.01). Median tumour weight was significantly lower in group A: 280 mg (range 50-3710) versus 573 mg (range 10-12,000; P < 0.01). Overall rate of multiple gland disease (MGD) was 11%; 24% in group A and 7% in group B (P < 0.01). Overall rate of UNE in Group A was 28% and converse to the rate in Group B (76%; P < 0.01). Sensitivity and specificity of ioPTH to detect MGD were 98 and 98% in Group A versus 98 and 100% in Group B. First-time cure rate was 92.7% in group A and 96.8% in group B (P < 0.05).
A double negative scan is associated with small tumours and higher rates of MGD. Despite these challenges, surgery is successful in this group of patients reinforcing the message that negative localisation is not a contraindication for parathyroidectomy. We demonstrated that it is feasible to offer unilateral neck surgery to 28% of patients with double negative scans. A randomised trial is needed to compare BNE with ioPTH/UNE in this select population.
超声和99m锝-甲氧基异丁基异腈(Tc99mMIBI)扫描用于定位散发性原发性甲状旁腺功能亢进症(pHPT)中的甲状旁腺肿瘤。术中甲状旁腺激素(ioPTH)检测有助于进行单侧颈部探查(UNE)。当超声和MIBI检查结果均为阴性时,我们的策略是探查颈部左侧,只有在未发现肿瘤或ioPTH未降至切除前最高值的>50%时,才进行双侧颈部探查(BNE)。本研究的目的是调查我们针对“双阴性”患者的治疗方法的结果。
对因pHPT接受原发性甲状旁腺切除术的患者进行回顾性分析。数据来自前瞻性手术数据库和医院电子病历。
2004年1月至2014年11月期间,746例患者因pHPT接受了甲状旁腺切除术。排除那些未进行术前扫描、ioPTH检测或至少6个月随访的患者。在552例患者中,111例(20%)扫描结果为双阴性(A组),441例患者中,一项或两项扫描结果为阳性(B组)。中位年龄为61.5岁(范围10 - 88岁)。A组术前PTH水平显著较低:11.8 pmol/l(范围3.1 - 38.8),而B组为14.9 pmol/l(范围2.8 - 101.6;P < 0.01)。A组肿瘤中位重量显著较低:280 mg(范围50 - 3710),而B组为573 mg(范围10 - 12,000;P < 0.01)。多腺体疾病(MGD)的总体发生率为11%;A组为24%,B组为7%(P < 0.01)。A组UNE的总体发生率为28%,与B组发生率相反(76%;P < 0.01)。ioPTH检测MGD的敏感性和特异性在A组分别为98%和98%,在B组分别为98%和100%。A组首次治愈率为92.7%,B组为96.8%(P < 0.05)。
双阴性扫描与肿瘤较小和MGD发生率较高相关。尽管存在这些挑战,但该组患者手术仍成功,这进一步表明定位阴性并非甲状旁腺切除术的禁忌证。我们证明,对于28%扫描结果为双阴性的患者,进行单侧颈部手术是可行的。需要进行一项随机试验,以比较在这一特定人群中BNE与ioPTH/UNE的效果。